AbD Serotec (formerly Antibodies by Design)

Rapid production of custom recombinant monoclonal antibodies as reagents for research, diagnostics and drug discovery

AbD Serotec (Antibodies Direct)(formerly Antibodies by Design) is a division of MorphoSys AG.
MorphoSys AG, located in Martinsried (Munich), is one of the world’s leading biotechnology companies focusing on antibodies. The Company’s technologies emphasize the use of human antibodies in both research and therapeutic applications. MorphoSys applies these innovative and proprietary technologies in order to discover disease related targets and new drugs for itself and its commercial partners. MorphoSys has led the emergence of the biotechnology sector in Germany and now plays a key role globally in the human antibody sector. Founded in 1992 by Dr. Simon E. Moroney, Prof. Dr. Andras Plückthun and Christian Schneider, thecompany’s product pipeline comprises more than 20 partnered and proprietary antibody therapeutic development programs. Since this time, the Company has entered into several partnerships with renowned companies from the pharmaceuticals and biotechnology sector.

Simon Moroney (CEO)
Dave Lemus (CFO)
Marlies Sproll (CSO)

Lena-Christ-Str. 48
82152 Martinsried/Planegg
Germany
Phone: +49-89-899-270
Fax: +49-89-899-27222

HuCAL® libraries